Validating a HealthTech MVP: How to Test for Market Fit

Martin Sandhu
Martin Sandhu

November 2025

Why does MVP validation look different in healthtech?

In consumer tech, an MVP can be scrappy and launched quickly. In healthtech, however, users handle sensitive data, clinical workflows, or regulated tasks. A rough MVP can break trust or create safety risks. Validation must balance speed with responsibility.

Healthtech founders need to test early, but with structure, ethics, and real-world clinical context.

What should a healthtech MVP aim to validate?

An MVP shouldn’t try to prove everything — only the assumptions most likely to determine success.

Key validation targets include:

  • Does the product solve a real clinical or operational problem?
  • Can intended users complete critical tasks safely and confidently?
  • Does the workflow make sense in context?
  • Is the value proposition meaningful enough for adoption?
  • Are clinicians or patients willing to use it consistently?
  • Does the product integrate into real-world systems?

An MVP is a lens for truth, not a half-built product.

How do you structure early user testing?

1. Recruit representative participants

Test with actual clinicians, admins, or patients — not internal staff.

2. Focus on realistic scenarios

Simulate the actual environment: hectic clinics, telehealth visits, administrative pressure.

3. Observe silently

Let users struggle if they need to. Their difficulties are data.

4. Prioritise critical tasks

These are the actions that must work for the product to be viable.

5. Capture emotional responses

Frustration is a signal. Confidence is a milestone.

Healthcare UX is as much emotional as it is functional.

What role do pilots play in validation?

Pilots bridge the gap between usability testing and large-scale deployment. Good pilots:

  • Take place in real clinical settings
  • Measure specific outcomes
  • Include both qualitative and quantitative data
  • Reveal integration risks
  • Stress-test scalability
  • Uncover operational constraints

A well-run pilot gives startups evidence that resonates with investors and procurement teams.

How should founders decide what to iterate next?

Use this tiered decision model:

Tier 1: Safety and usability issues

Fix anything that creates risk or confusion.

Tier 2: Workflow blockers

Address steps that slow clinics or overwhelm users.

Tier 3: Value enhancements

Improve clarity, visual design, or automation opportunities.

Evidence — not opinion — determines priority.

What mistakes do early-stage teams often make?

  • Testing with the wrong user group
  • Overbuilding before validation
  • Ignoring integration constraints
  • Collecting data but not analysing it
  • Seeking confirmation instead of insight
  • Fearing negative feedback

The goal is not to prove yourself right.
It is to eliminate unknowns that prevent growth.

Why does strong MVP validation accelerate fundraising and adoption?

Investors and clinical partners trust products that demonstrate:

  • Real-world usability
  • Clear demand
  • Repeatable workflows
  • Early outcome signals
  • Operational feasibility
  • Scalable potential

Validation de-risks the startup — and in healthtech, de-risking is everything.

Like this?

More

HealthTech

insights

View more insights

Contact us

Let’s talk

We create human-centered solutions that drive positive outcomes for users and organisations. Let’s collaborate.

See our work
nuom
Typically replies in a few hours
nuom
Hi there!
How can we help you today?
Start Whatsapp Chat
WhatsApp icon